CHinese ischEmic Stroke Beyond 4.5 Hours With TeNecteplase Under Optimized Non-Contrast CT Selection
A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 890 participants.
Also called NCT06994975
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 890 participants
- Sponsor
- Registry
-
NCT06994975
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Recruiting
Technical summary
Registry record NCT06994975. Randomized; single masking; primary purpose treatment. Start 2025-11-03 (actual); primary completion 2028-03 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- CHinese ischEmic Stroke Beyond 4.5 Hours With TeNecteplase Under Optimized Non-Contrast CT Selection
- Acronym
- CHESTNUT
- Condition
- Acute Ischemic Stroke
- Intervention (Drug)
- 0.25mg/kg TNK
- Intervention (Drug)
- Standard medical treatment
- Lead sponsor
- Huashan Hospital
Record details
- Record id
cardio:ct-nct06994975- Content hash
f77909d1d2ddbe3a8f32d67a7d2c8ef7a5cd48906ea9c00dfd2cf8dd1e87b6e5